Synopsys chair sells 25,000 shares after option exercise
For SYNOPSYS INC (SNPS), Executive Chair Aart de Geus reported an option exercise and related share sale.
Rhea-AI Filing Summary
For SYNOPSYS INC (SNPS), Executive Chair Aart de Geus reported an option exercise and related share sale. On 2026-08-28 he exercised 25,000 Non-Qualified Stock Options at an exercise price of $135.88 per share, acquiring an equal number of SNPS common shares. On the same date, he sold 25,000 common shares at a weighted average price of $445.5502 per share in multiple transactions. Following these transactions, he directly held 49,641 shares, and indirectly held 308,791 shares through a Family Trust and 14,500 shares through a Partnership. The filing states that these transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 14, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 25,000 shares ($7.74M approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
DE GEUS AART
Role
EXECUTIVE CHAIR
Sold
25,000 shs ($11.14M)
Approx. gross sale proceeds
$11.14M
Approx. exercise cost
$3.40M
Approx. pre-tax spread
$7.74M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F2 | 25,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 25,000 | $135.88 | $3.40M |
| Sale | Common Stock F1 | 25,000 | $445.5502 | $11.14M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 49,641 contracts (Direct);
Common Stock — 120,421 shares (Direct);
Common Stock — 308,791 shares (Indirect, by Family Trust);
Common Stock — 14,500 shares (Indirect, by Partnership)
Footnotes (2)
- F1. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $440.985 to $461.850. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F2. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025.
Key Figures
Options Exercised: 25,000 shares of Non-Qualified Stock Options
Exercise Price: $135.88 per share
Shares Sold: 25,000 shares of Common Stock
+5 more
8 metrics
Options Exercised
25,000 shares of Non-Qualified Stock Options
Exercised on 2026-08-28 at an exercise price of $135.88 per share
Exercise Price
$135.88 per share
Exercise price of Non-Qualified Stock Option expiring 2026-12-12
Shares Sold
25,000 shares of Common Stock
Sale transaction on 2026-08-28
Weighted Average Sale Price
$445.5502 per share
Weighted average sale price for 25,000 shares, with prices from $440.985 to $461.850
Direct Holdings After Transaction
49,641 shares of Common Stock
Direct ownership position following reported transactions
Indirect Holdings via Family Trust
308,791 shares of Common Stock
Indirect ownership described as held "by Family Trust"
Indirect Holdings via Partnership
14,500 shares of Common Stock
Indirect ownership described as held "by Partnership"
Rule 10b5-1 Plan Adoption Date
October 14, 2025
Plan under which the reported transactions were effected
Key Terms
Non-Qualified Stock Option, Rule 10b5-1 trading plan, weighted average sale price per share, Family Trust, +1 more
5 terms
Non-Qualified Stock Option financial
"security_title: "Non-Qualified Stock Option (right to buy)""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Rule 10b5-1 trading plan regulatory
"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Family Trust financial
"nature_of_ownership: "by Family Trust""
Partnership financial
"nature_of_ownership: "by Partnership""
FAQ
What did Aart de Geus report in this Form 4 for SNPS?
He exercised 25,000 stock options at an exercise price of $135.88 per share and sold 25,000 common shares at a weighted average price of $445.5502 per share on 2026-08-28.
Were the SNPS trades by Aart de Geus under a Rule 10b5-1 plan?
Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan that was adopted October 14, 2025.
What type of derivative security did Aart de Geus exercise on SNPS?
He exercised a Non-Qualified Stock Option (right to buy) covering 25,000 shares of Synopsys common stock, with an exercise price of $135.88 per share and an expiration date of 2026-12-12.
AI-generated analysis. How Rhea-AI works. Not financial advice.
